Zevra Therapeutics, Inc. (ZVRA)
11.74
+0.18
(+1.51%)
USD |
NASDAQ |
Aug 31, 16:00
11.74
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Total Long Term Debt (Quarterly) : 0.87M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.87M |
| March 31, 2026 | 0.741M |
| December 31, 2025 | 62.79M |
| September 30, 2025 | 62.28M |
| June 30, 2025 | 61.75M |
| March 31, 2025 | 61.25M |
| December 31, 2024 | 59.88M |
| September 30, 2024 | 59.39M |
| June 30, 2024 | 58.87M |
| March 31, 2024 | 43.70M |
| December 31, 2023 | 43.22M |
| September 30, 2023 | 44.39M |
| June 30, 2023 | 13.34M |
| March 31, 2023 | 13.66M |
| December 31, 2022 | 13.65M |
| September 30, 2022 | 13.76M |
| June 30, 2022 | 13.89M |
| March 31, 2022 | 1.155M |
| December 31, 2021 | 1.253M |
| September 30, 2021 | 1.363M |
| June 30, 2021 | 1.475M |
| March 31, 2021 | 2.414M |
| December 31, 2020 | 70.22M |
| September 30, 2020 | 68.61M |
| Date | Value |
|---|---|
| June 30, 2020 | 70.09M |
| March 31, 2020 | 70.79M |
| December 31, 2019 | 79.65M |
| September 30, 2019 | 79.70M |
| June 30, 2019 | 84.60M |
| March 31, 2019 | 83.88M |
| December 31, 2018 | 82.05M |
| September 30, 2018 | 91.16M |
| June 30, 2018 | 90.83M |
| March 31, 2018 | 93.82M |
| December 31, 2017 | 93.48M |
| September 30, 2017 | 92.52M |
| June 30, 2017 | 92.13M |
| March 31, 2017 | 91.72M |
| December 31, 2016 | 91.33M |
| September 30, 2016 | 90.88M |
| June 30, 2016 | 92.42M |
| March 31, 2016 | 91.75M |
| December 31, 2015 | 23.10M |
| September 30, 2015 | 63.13M |
| June 30, 2015 | 20.14M |
| March 31, 2015 | 18.60M |
| December 31, 2014 | 34.11M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Innoviva, Inc. | 268.94M |
| Collegium Pharmaceutical, Inc. | 1.216B |
| Johnson & Johnson | 37.34B |
| Ligand Pharmaceuticals, Inc. | 1.130B |
| Harrow, Inc. | 299.80M |